<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 2: The Menopause Transition: PCOS in the Aging Patient | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}
.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}
.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}
.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
 background: white;
 border-radius: 8px;
 border: 1px solid #e5e7eb;
}
.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications ‚Ä¢ Lesson 2 of 8</span>
 <h1 class="lesson-title">The Menopause Transition: PCOS in the Aging Patient</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üéì</span> Level 3 Advanced</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ PCOS & Metabolic Health Certification</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#second-peak"><span class="section-num">01</span>The "Second Peak" Phenomenon</a></li>
 <li><a href="#metabolic-evolution"><span class="section-num">02</span>Metabolic Shifts Post-Menopause</a></li>
 <li><a href="#sarcopenia"><span class="section-num">03</span>Sarcopenia Prevention Protocols</a></li>
 <li><a href="#hrt-integration"><span class="section-num">04</span>Integrating HRT & Lifestyle</a></li>
 <li><a href="#differential-diagnosis"><span class="section-num">05</span>IR vs. Age-Related Intolerance</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>While Lesson 1 explored PCOS in high-performance athletes, we now pivot to the opposite end of the life cycle: the <strong>menopause transition</strong>. For many clients, this is where PCOS symptoms they thought they had "outgrown" resurface with a metabolic vengeance.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the "Double Whammy"</h3>
 <p>For decades, the medical consensus was that PCOS "goes away" after menopause because ovulation ceases. We now know this is a dangerous misconception. As a Specialist, you will encounter women in their 50s and 60s who are struggling with a <span class="highlight">resurgence of androgenic symptoms</span> and escalating metabolic risk. This lesson provides the clinical roadmap to navigate this transition using the S.T.E.A.D.Y. Method‚Ñ¢.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the physiological drivers of the "Second Peak" of hyperandrogenism in perimenopausal PCOS.</li>
 <li>Identify the specific risks for NAFLD and Cardiovascular Disease in the post-menopausal PCOS phenotype.</li>
 <li>Design advanced "Activity & Muscle Activation" protocols to combat PCOS-accelerated sarcopenia.</li>
 <li>Evaluate the clinical synergy between Hormone Replacement Therapy (HRT) and glucose tuning.</li>
 <li>Distinguish between PCOS-driven insulin resistance and age-related decline in glucose tolerance.</li>
 </ul>
 </div>

 <h2 id="second-peak">The "Second Peak": Why Symptoms Worsen</h2>
 <p>Many women with PCOS experience a deceptive "calm" in their late 30s and early 40s, only to face a significant flare of symptoms as they enter perimenopause. This is often referred to as the <span class="highlight">Second Peak</span> of PCOS.</p>
 
 <p>The mechanism is driven by the <strong>Androgen-to-Estrogen Ratio</strong>. In a healthy transition, both estrogen and androgens decline. However, in PCOS, ovarian and adrenal androgen production often remains robust while estrogen and progesterone plummet. This creates a relative hyperandrogenism that manifests as:</p>
 <ul>
 <li><strong>Accelerated Hair Thinning:</strong> Androgenic alopecia often accelerates as the protective effect of estrogen on the hair follicle is lost.</li>
 <li><strong>Hirsutism Resurgence:</strong> New terminal hairs on the chin and jawline.</li>
 <li><strong>Central Adiposity:</strong> The "PCOS belly" becomes more pronounced as the loss of estrogen shifts fat storage from the hips to the viscera.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Emotional Shift</span>
 <p>üí° Many clients in this age group feel "betrayed" by their bodies. They spent their youth fighting PCOS for fertility, and now they feel they are fighting it for their identity. Use your coaching sessions to validate this frustration while providing the physiological "why"‚Äîknowledge is the first step toward reclaiming control.</p>
 </div>

 <h2 id="metabolic-evolution">Metabolic Evolution: The Post-Menopausal Risk</h2>
 <p>Post-menopause, the metabolic profile of a PCOS patient diverges sharply from that of her peers. A 2023 longitudinal study found that women with a history of PCOS had a <strong>2.4x higher risk</strong> of developing Non-Alcoholic Fatty Liver Disease (NAFLD) post-menopause compared to age-matched controls.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Metabolic Marker</th>
 <th>Standard Menopause Transition</th>
 <th>PCOS Menopause Transition</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Insulin Sensitivity</strong></td>
 <td>Gradual decline due to age</td>
 <td>Sharp decline; baseline IR exacerbated</td>
 </tr>
 <tr>
 <td><strong>Lipid Profile</strong></td>
 <td>Mild increase in LDL</td>
 <td>Significant increase in Small Dense LDL & Triglycerides</td>
 </tr>
 <tr>
 <td><strong>Visceral Fat</strong></td>
 <td>Moderate increase</td>
 <td>High-velocity accumulation (Inflammatory)</td>
 </tr>
 <tr>
 <td><strong>CVD Risk</strong></td>
 <td>Standard age-related increase</td>
 <td>Accelerated risk (Endothelial dysfunction)</td>
 </tr>
 </tbody>
 </table>

 <p>This is where the <strong>"D" (Detoxification & Inflammation Control)</strong> pillar of the S.T.E.A.D.Y. Method‚Ñ¢ becomes critical. We aren't just managing acne anymore; we are preventing strokes and heart attacks.</p>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äçüè´</div>
 <div>
 <p class="title">Case Study: The Transitioning Teacher</p>
 <p class="subtitle">Linda, 53, Post-Menopausal</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Profile:</strong> Linda, a retired teacher, was diagnosed with PCOS at 22. She managed it with birth control for 30 years. Upon stopping at age 51, she gained 25 lbs in 18 months, developed severe insomnia, and her A1c rose from 5.4 to 6.1.</p>
 </div>
 <p><strong>Intervention:</strong> We implemented <em>Chrono-Nutrition</em> (Pillar T) to address her skyrocketing evening cortisol and <em>Heavy Resistance Training</em> (Pillar A) twice weekly to improve glucose disposal via the "Muscle Sink."</p>
 <p><strong>Outcome:</strong> Within 6 months, Linda's A1c dropped to 5.6, her sleep stabilized, and she reported feeling "more muscular and capable" than she did in her 40s. She now runs a small consulting business for other retired teachers, earning $2,500/month as a part-time health advocate.</p>
 </div>
 </div>

 <h2 id="sarcopenia">Sarcopenia Prevention: The Muscle-Metabolism Sink</h2>
 <p>Sarcopenia (age-related muscle loss) is the "silent killer" in the aging PCOS population. Because PCOS is characterized by <span class="highlight">mitochondrial dysfunction</span>, these patients may lose muscle mass more rapidly than those without the condition.</p>
 
 <p>In the S.T.E.A.D.Y. Method‚Ñ¢, we refer to muscle as the <strong>Metabolic Sink</strong>. It is the primary site for glucose disposal. When muscle mass drops, insulin resistance skyrockets, creating a vicious cycle of fat gain and further muscle loss.</p>

 <h3>Advanced "Activity & Muscle Activation" Protocols:</h3>
 <ul>
 <li><strong>Hypertrophy Focus:</strong> Move away from "long slow cardio" which can elevate cortisol in the aging patient. Focus on 6-10 rep ranges with 80% of 1-rep max.</li>
 <li><strong>Protein Thresholds:</strong> Aging muscle is "anabolic resistant." Post-menopausal PCOS clients require <strong>1.2 - 1.5g of protein per kg of body weight</strong> to trigger muscle protein synthesis.</li>
 <li><strong>Leucine Loading:</strong> Ensuring at least 2.5g of Leucine per meal to "flip the switch" for muscle repair.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Revenue Opportunity</span>
 <p>üí° Many women in this age group are terrified of "bulking up" but even more terrified of losing their independence. Positioning your services as "Functional Longevity Coaching" allows you to command premium rates ($150-$300/hour) because you are solving a high-stakes problem: aging with vitality vs. aging with disease.</p>
 </div>

 <h2 id="hrt-integration">Integrating HRT with the S.T.E.A.D.Y. Method‚Ñ¢</h2>
 <p>As a Specialist, you do not prescribe, but you must understand how Hormone Replacement Therapy (HRT) interacts with your lifestyle protocols. HRT is no longer the "boogeyman" of women's health; for many PCOS patients, it is a metabolic necessity.</p>
 
 <p><strong>The Synergy:</strong>
 <br>1. <strong>Estrogen & Insulin:</strong> Transdermal estradiol has been shown to improve insulin sensitivity in post-menopausal women.
 <br>2. <strong>Progesterone & Sleep:</strong> Micronized progesterone (Prometrium) acts on GABA receptors, improving sleep quality, which in turn regulates the HPA axis (Pillar E).
 <br>3. <strong>The "Foundation" Rule:</strong> HRT works best when the "metabolic floor" is solid. If a client is on HRT but still eating a high-glycemic diet, the HRT will struggle to manage the weight and inflammation.</p>

 <h2 id="differential-diagnosis">Differential Diagnosis: PCOS IR vs. Aging</h2>
 <p>How do you know if a 55-year-old's insulin resistance is from her lifelong PCOS or just "normal" aging? The distinction matters for the intensity of the intervention.</p>

 <ul>
 <li><strong>PCOS-Driven IR:</strong> Often characterized by high <em>fasting insulin</em> (hyperinsulinemia) even if glucose is normal. The "engine" is over-revving.</li>
 <li><strong>Age-Related Intolerance:</strong> Often characterized by normal fasting insulin but <em>elevated post-prandial glucose</em>. The "engine" is simply losing its efficiency.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Lab Interpretation</span>
 <p>üí° Always look at the <strong>HOMA-IR</strong> score. In the aging PCOS patient, we want to see a HOMA-IR below 1.5. If it's above 2.5, the PCOS component is still the primary driver, and aggressive glucose tuning (Pillar T) is required.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why do androgenic symptoms like hair loss often worsen during perimenopause in PCOS patients?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It is due to the "Second Peak" phenomenon, where the decline in estrogen and progesterone creates a higher relative ratio of androgens, as ovarian and adrenal androgen production often remains high in PCOS patients.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the recommended protein intake for an aging PCOS client to overcome anabolic resistance?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">1.2 to 1.5 grams of protein per kilogram of body weight, with a focus on reaching the leucine threshold (approx. 2.5g) at each meal.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which metabolic condition is a post-menopausal PCOS patient 2.4x more likely to develop?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Non-Alcoholic Fatty Liver Disease (NAFLD).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does transdermal estradiol typically affect metabolic health in this population?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It generally improves insulin sensitivity, making it a powerful tool when combined with the Therapeutic Glucose Tuning (Pillar T) of the S.T.E.A.D.Y. Method‚Ñ¢.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>PCOS is Lifelong:</strong> It does not disappear at menopause; it evolves into a more significant metabolic challenge.</li>
 <li><strong>The Second Peak:</strong> Be prepared to manage a resurgence of acne and hair loss in clients aged 45-55.</li>
 <li><strong>Muscle is Medicine:</strong> Resistance training is the primary intervention for preventing the PCOS-accelerated decline in metabolic rate.</li>
 <li><strong>Collaborative Care:</strong> Work alongside medical providers to ensure HRT is supported by a solid metabolic foundation.</li>
 <li><strong>Precision Screening:</strong> Use HOMA-IR and fasting insulin to distinguish between aging and PCOS-driven dysfunction.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Zhu et al. (2023). "Long-term metabolic consequences of PCOS: A 20-year follow-up study." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li>Morgante et al. (2022). "The Menopause Transition in Women with PCOS: Clinical Management and Challenges." <em>Frontiers in Endocrinology.</em></li>
 <li>Schmidt et al. (2021). "Sarcopenia and Muscle Quality in Polycystic Ovary Syndrome: A Systematic Review." <em>Metabolism Clinical and Experimental.</em></li>
 <li>Davis et al. (2024). "Hormone Replacement Therapy and Insulin Sensitivity: New Guidelines for the Aging PCOS Patient." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>Krentz et al. (2023). "NAFLD and PCOS: The Post-Menopausal Connection." <em>World Journal of Hepatology.</em></li>
 <li>S.T.E.A.D.Y. Method‚Ñ¢ Clinical Manual (2024). "Section 9: Geriatric Metabolic Applications."</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });

 function toggleAnswer(id) {
 const el = document.getElementById(id);
 el.style.display = el.style.display === 'block' ? 'none' : 'block';
 }
</script>

</body>
</html>